Comparison | p-value |
|---|
| Â | sST2 | BNP | hs-CRP |
|---|
A vs B | 0,514 | 0,628 | 0,872 |
A vs C |
0,007
| 0,213 |
0,004
|
A vs D |
<0,001
| 0,207 |
0,017
|
B vs C | 0,121 | 0,863 |
0,041
|
B vs D |
<0,001
| 0,504 |
0,048
|
C vs D |
0,001
| 0,091 | 0,659 |
Overall
|
<0,001
| 0,301 |
0,039
|
- Soluble ST2 was significantly different between group A (healthy controls) and patients with type 2 diabetes without (group C) LVDD (p = 0.007). Moreover, patients with type 2 diabetes with LVDD (group D) had the highest mean serum level of sST2 compared to the correspondent of the rest 3 subject groups: group A (p < 0.001), group B (p < 0.001) and group C (p = 0.001). The respective mean values of BNP for the 4 study groups could not achieve statistical difference. All subjects with type 2 diabetes presented higher hs-CRP levels compared to the non-diabetic population of the study.
